New Drug for Use in Bone Scans Approved - National Cancer Institute
Links shared publicly online about this topic.
- 536total visits
New Drug for Use in Bone Scans Approved - National Cancer Institute
The FDA has approved a New Drug Application (NDA) from NCI for a new strength of a previously approved drug, Sodium Fluoride F18, for use in bone scans. In contrast to Technetium-99m, which has been the only approved radioactive tracer for bone scans, Sodium Fluoride F18 is not subject to the supply problems.
View full resource at cancer.gov
Tags: Cancer, Bone, Mineral, Sodium, Drug, FDA, News
Most Recently Shared on February 2, 2011 at 3:43 pm By:
NCI news: FDA has approved an NDA from NCI, providing alternative to radioactive tracer in short supply http://j.mp/eHHQnS
Advertisement
